Breastfeeding is no longer universally contraindicated for mothers living with HIV. For decades, the standard advice in high-resource countries was to avoid breastfeeding entirely. That has changed. When a mother takes HIV treatment consistently and maintains an undetectable viral load, the risk of transmitting HIV through breast milk drops to less than 1%. Both the WHO and U.S. health agencies now support breastfeeding as one of several options for mothers who meet specific conditions.
How Guidelines Have Shifted
The old blanket recommendation against breastfeeding was based on a real concern: HIV can pass through breast milk. Without treatment, the cumulative risk of transmission over months of breastfeeding is significant. But modern HIV treatment changed the equation. Antiretroviral therapy (ART) suppresses the virus in both blood and breast milk to undetectable levels, and that suppression dramatically reduces transmission risk.
The WHO now recommends that in settings where breastfeeding is supported, mothers living with HIV should exclusively breastfeed for the first 6 months, then continue alongside solid foods for at least 12 months and up to 24 months or longer, as long as they stay on ART. In these guidelines, breastfeeding duration should not be restricted when the mother has reliable access to treatment and support for staying on it.
In the United States, the shift came more recently. The American Academy of Pediatrics updated its position in 2024, stating that pediatricians should take a “family-centered, nonjudgmental, harm reduction approach” to support mothers with HIV who are on ART with a sustained viral load below 50 copies per mL and who want to breastfeed. The NIH guidelines now recommend counseling mothers about three options: formula feeding, banked donor milk, or breastfeeding. Those who choose to breastfeed should be supported in that decision.
The Transmission Risk With Treatment
The key number is less than 1%. That’s the estimated risk of HIV transmission through breastfeeding when the mother maintains viral suppression on ART throughout pregnancy and the postpartum period. This is not zero, and guidelines are transparent about that. But it represents a dramatic reduction from the pre-treatment era and is now considered low enough that breastfeeding’s nutritional and immunological benefits can factor into the decision.
The critical condition is sustained viral suppression. The threshold used by the American Academy of Pediatrics is fewer than 50 copies of virus per milliliter of blood. Missing doses of medication, interrupting treatment, or having a viral rebound changes the risk profile entirely. If a breastfeeding mother’s viral load becomes detectable, some experts recommend monthly testing of the infant rather than the standard quarterly schedule.
What Passes Into Breast Milk
HIV treatment medications do transfer into breast milk, but the amounts are small. A Swiss study measuring drug levels in breast milk found that the estimated daily dose an infant receives through breastfeeding stayed below the standard safety threshold (less than 10% of the mother’s weight-adjusted dose) for all medications tested. Some drugs barely cross into milk at all. One commonly used medication, bictegravir, had a milk-to-plasma ratio of just 0.01, meaning virtually none reached the milk.
One nuance worth noting: because the drug levels in milk are low, they may not be high enough to fully protect an infant if transmission did occur. This raises a theoretical concern about drug resistance developing in the rare case of infection during breastfeeding. It’s not a reason to avoid breastfeeding on its own, but it’s part of why ongoing infant testing matters.
Testing Schedule for Breastfed Infants
Infants breastfed by mothers with HIV follow a more intensive testing schedule than formula-fed infants. Viral testing (not antibody tests, which would pick up the mother’s antibodies) is recommended at birth, 14 to 21 days, 1 to 2 months, and 4 to 6 months. If breastfeeding continues past 6 months, testing should happen at least every 3 months for the entire duration.
Testing doesn’t stop when breastfeeding ends. After the last feeding, infants need additional viral tests at 4 to 6 weeks and again at 4 to 6 months post-weaning, regardless of the age when breastfeeding stops. This extended follow-up catches any transmission that may have occurred in the final weeks of nursing.
Exclusive Breastfeeding vs. Mixed Feeding
Earlier research from the pre-ART era found that exclusive breastfeeding carried lower transmission risk than mixed feeding, where infants received both breast milk and other foods or liquids. The theory is that formula, water, or solid foods can irritate an infant’s gut lining, creating small entry points for the virus. While ART has made this distinction less critical, the WHO still recommends exclusive breastfeeding for the first 6 months before introducing complementary foods, which aligns with general infant feeding advice for all mothers.
Alternatives to Direct Breastfeeding
For mothers who prefer not to breastfeed directly, two main alternatives exist. Formula feeding eliminates HIV transmission risk entirely and remains a valid choice, particularly in settings with clean water and reliable access to formula. Banked donor milk is another option. Milk banks affiliated with the Human Milk Banking Association of North America screen all donors with blood tests for HIV and pasteurize every batch at 62.5°C (about 145°F) for 30 minutes, which inactivates the virus.
There’s also a low-tech option for mothers who want their infant to receive their own milk without the transmission risk. Flash-heating involves placing expressed milk in a glass jar set inside a pot of water, then heating the water to a rolling boil. The milk typically reaches about 73 to 79°C, which is enough to inactivate HIV while preserving most of the milk’s nutritional and immune properties. The whole process takes around 12 minutes. This method was developed for resource-limited settings but can be used anywhere.
What Makes This a Personal Decision
The reason guidelines now frame this as a shared decision rather than a prohibition is that the risk-benefit calculation genuinely differs depending on circumstances. Breast milk provides antibodies, supports gut development, and reduces the risk of infections, allergies, and other conditions in infancy. For some families, those benefits, combined with the bonding experience, outweigh a sub-1% transmission risk. For others, the priority is eliminating that risk entirely.
What all guidelines agree on: this decision works only when the mother is on effective HIV treatment, maintains an undetectable viral load, has consistent access to medication and medical follow-up, and the infant receives regular viral testing throughout the breastfeeding period and after weaning. Without those conditions in place, the risk calculus shifts considerably.